Bengaluru-based health technology startup Ultrahuman has announced a significant strategic partnership with the Abu Dhabi Public Health Center (ADPHC) aimed at redefining preventive healthcare through the creation of a sophisticated biological-age model. This collaboration, formalized through a two-year memorandum of understanding signed this week, seeks to integrate clinical biomarkers with real-time data harvested from wearable devices. The ultimate goal is to provide a comprehensive health-tracking system that will be available to residents across the United Arab Emirates, marking a pivotal shift for the startup as it transitions from a hardware-centric model to a large-scale data and analytics entity.
The initiative focuses on quantifying the aging process, allowing individuals to gain a clearer understanding of how various lifestyle factors influence their long-term health. By analyzing data points such as sleep patterns, daily physical activity, cardiovascular metrics, and metabolic health, the proposed model aims to identify specific variables that either accelerate or decelerate an individual’s biological decline. This development represents a significant departure from traditional healthcare models, which often prioritize reactive treatment over proactive, data-driven prevention.
For Ultrahuman, this partnership is a critical milestone in its efforts to scale its proprietary algorithms beyond its immediate customer base. Since its inception, the company has gained widespread recognition for its Ultrahuman Ring, a wearable device designed to collect nuanced physiological data. However, CEO Mohit Kumar has consistently emphasized that the company’s vision extends far beyond the physical form factor of the ring itself. In an interview, Kumar clarified that while the hardware serves as an essential gateway for acquiring high-fidelity body data, the company’s true value proposition lies in the sophisticated application of that data to drive insights into longevity, metabolic health, and aging.
"If you look at Ultrahuman as a company, we obviously have the Ultrahuman Ring, which is a way to acquire data from the human body," Kumar explained. "But truly, what we care about is not just the form factor, the ring, but what do we do with this data?"
The partnership with the Abu Dhabi government provides a unique opportunity to apply these algorithms to a much broader and more diverse demographic than the startup’s current customer base. To date, Ultrahuman has sold approximately 800,000 smart rings worldwide. While this figure represents a robust commercial footprint, it is limited to a specific segment of the population—typically users between the ages of 25 and 43 who are interested in wellness and performance tracking. By integrating its model into government digital-health platforms like TAMM and Sahatna, Ultrahuman stands to reach a significantly wider age range and socioeconomic demographic, allowing for a more accurate and representative validation of its longevity algorithms.
Despite the company’s reputation as a wearable hardware manufacturer, Kumar noted that the biological-age model is being designed to be "wearable-agnostic." This means the system will not be locked to the Ultrahuman Ring; rather, it is engineered to ingest data from a variety of sources, including wrist-worn devices, straps, and patches, alongside clinical biomarkers. This interoperability is essential for a national-scale rollout, ensuring that citizens can participate regardless of their preferred device ecosystem.
The two-year timeline for the partnership will be dedicated to rigorous research and clinical validation. While the company has not yet provided a specific date for a public launch, the rollout is expected to occur in carefully managed phases. The project will leverage the existing data foundations built by Ultrahuman, which has already been mapping how various health markers shift across different chronological ages. By comparing a user’s current data against these established patterns, the model can highlight significant deviations, providing users with actionable insights into their health trajectory.
The United Arab Emirates represents a key market for the Bengaluru startup. Having operated in the region for nearly five years, the UAE currently stands as one of Ultrahuman’s top ten global markets, contributing between 4% and 5% of its total revenue. Furthermore, the company reports a 25% higher customer retention rate in the UAE compared to its other international markets, suggesting a high level of engagement and adoption within the local population.
Data privacy and security remain at the forefront of the collaboration. Kumar was quick to address concerns regarding the use of national data, stressing that the model will not be trained using information belonging to UAE citizens. Instead, the company plans to deploy its existing, pre-trained algorithm onto the regional datasets, ensuring that the local deployment remains secure. Furthermore, the startup will not have access to personally identifiable information throughout the program, maintaining strict adherence to privacy regulations.
The landscape of preventive health in the Middle East is becoming increasingly competitive, with government authorities actively seeking partnerships with global tech innovators. Earlier this year, in May, the Department of Health – Abu Dhabi announced a separate partnership with Oura, a prominent rival in the smart-ring market. That collaboration focuses on combining Oura’s wearable data with the emirate’s longitudinal health records, with an initial emphasis on women’s health and cardiometabolic risks.
When asked about the competitive landscape, Kumar acknowledged that the government works with multiple health-tech providers but noted that Ultrahuman is not aware of any other entity currently collaborating with Abu Dhabi authorities on a biological-age model of this specific nature. He declined to comment on the specific scope of Oura’s work in the region, focusing instead on the potential for Ultrahuman to continue expanding its software capabilities.
This strategic pivot toward software and health analytics comes at a time when Ultrahuman is aggressively investing in the future of wearable computing. The company is currently exploring ways to build smart rings capable of running software directly on the device, potentially powering everything from artificial intelligence-driven user interactions to gaming applications. This trajectory suggests that while the hardware is the initial point of contact, the company is positioning itself to be a comprehensive software provider in the health and longevity space.
The collaboration with the Abu Dhabi Public Health Center serves as a bridge between the niche world of consumer wearables and the broad, systemic requirements of public health policy. By moving into the domain of clinical validation and national-level health monitoring, Ultrahuman is signaling that it intends to be a long-term player in the digital transformation of healthcare. The success of this model could provide a blueprint for how other governments might utilize consumer-grade wearable data to improve public health outcomes, potentially setting a new standard for how biological age and metabolic health are monitored on a population scale.
As the research phase commences, the focus will remain on the efficacy of the data synthesis. The integration of clinical markers with real-time wearable signals is a complex undertaking that requires both technical precision and a deep understanding of human physiology. For the residents of the UAE, the promise is a more personalized approach to their own health, moving away from the "one-size-fits-all" advice of the past and toward a data-informed understanding of their own biological aging process. For Ultrahuman, the project is a definitive test of its ability to translate its data-gathering prowess into a tangible, government-backed public health service.
